电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

RSV 抗体

The 兔 多克隆 anti-RSV antibody is suitable to detect RSV in samples from Respiratory Syncytial Virus (RSV). It has been validated for WB.
产品编号 ABIN437960
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for RSV 抗体 (ABIN437960)

抗原

RSV (Respiratory Syncytial Virus (RSV))

适用

  • 70
  • 13
  • 13
  • 13
Respiratory Syncytial Virus (RSV)

宿主

  • 40
  • 25
  • 20

克隆类型

  • 40
  • 39
多克隆

标记

  • 42
  • 12
  • 9
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This RSV antibody is un-conjugated

应用范围

  • 42
  • 24
  • 23
  • 20
  • 13
  • 13
  • 11
  • 10
  • 8
  • 8
  • 8
  • 6
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • 纯化方法

    Aff - Purified

    免疫原

    Whole RSV virions (subgroup A-Long strain) were used as an immunogen. Detects G, F, N and M2 proteins of RSV.

    亚型

    IgG
  • 应用备注

    Optimal working dilutions should be determined experimentally by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    储存条件

    -20 °C
  • 抗原

    RSV (Respiratory Syncytial Virus (RSV))

    物质类

    Virus

    背景

    RSV is a negative sense RNA paramyxovirus in which the major virus neutralization antigens are the glycoprotein (G) and the fusion (F) protein that mediate attachment and fusion to the host cell during virus infection, respectively. Other RSV proteins include the nucleocapsid protein (N) and the M2 protein. The two major subgroups of RSV are A and B with the A strain being more virulent and responsible for the majority of severe RSV infections. Respiratory syncytial virus (RSV) infection is responsible for a large proportion of viral respiratory infections, and significant morbidity is associated with RSV infections. To date, few RSV vaccine candidates have shown promise with no human vaccine yet been proven safe and efficacious.
You are here: